Skip to main content
Loading

Bi/tri-specific strategies for cell engagers and other therapeutic applications

23 Sep 2024
Mendocino
Bi/Multispecifics
  • Mechanisms of Reduced Off-Target Effects
  • Controlled Activation and Dosing
  • Engineering for Improved Safety Profiles
Industry Expert
Lu Shan, Senior Director, Antibody Discovery and Protein Engineering - Alector